Loading…
Cooley LLP
Active litigationWhere Innovation Meets the Law
About
Cooley LLP is a global law firm that states it has "nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe", "400+ partners in a single-tier global partnership" and "a total workforce of more than 3,000 people worldwide". Its life sciences and healthcare practice states it represents companies across the "biotech, pharmaceutical, medtech, diagnostics and digital health services industries", spanning corporate, litigation, regulatory and intellectual property work. Its Life Sciences IP Litigation practice states "100+ IP professionals with doctorate and master's degrees" in science and engineering and "more than 400" inter partes review proceedings to date.
Strategic positioning
End-to-end counsel for emerging biotech — IP portfolio build, licensing, and the deals that monetize it.
Deterministic scores · rules-based, not AI iHow these scores are obtained: each one is computed from this profile's listed attributes — capability checkboxes, certifications, capacity figures and coverage — by a fixed formula, recomputed on every page load. Deterministic and rules-based means the score comes from a fixed, transparent formula over listed attributes — the same inputs always produce the same score. It is not AI: there is no model, no learning, and no hidden weighting. Whether a score is relevant to you depends on your specific project: a capability that raises the number may not matter for your work, and a niche strength your project needs may barely move it. Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
Manufacturing-IP focus iAdds 25 points if the firm declares a manufacturing-IP focus, plus 9 points per manufacturing technology area listed (sterile injectables, biologics, radiopharmaceuticals, biosimilars, drug-device combinations, mRNA/LNP), capped at 45, plus 8 points per manufacturing-IP service (CMC patents, trade secret governance, FTO opinions, patent term extension), capped at 30. Levels: 75+ Manufacturing-IP specialist | 50-74 Manufacturing-active | 25-49 Selective | below 25 Therapeutics-IP focused. Whether this dimension matters for you depends on your specific project.
26Selective
Life-sciences IP iAdds 4 points per technology area, capped at 30, plus 5 points per practice area, capped at 25, plus 4 points per jurisdiction, capped at 20, plus up to 25 points for technical depth based on the share of attorneys holding PhDs or advanced degrees. Levels: 80+ Premier life-sciences IP | 60-79 Strong | 40-59 Established | below 40 Emerging. Whether this dimension matters for you depends on your specific project.
57Established
Technology areas
Cell & gene therapyBiologicsAI drug discoverymRNA / LNPDiagnostics
Practice areas
Licensing & tech transferPatent prosecutionIP due diligencePatent portfolio strategyFreedom-to-operate (FTO)
Jurisdictions
USPTOEPOWIPO / PCT
CL
Cooley LLP
IP & patent counsel · United States
Live record · illustrative seed data · scores deterministic, rules-based — not AI.